Central Bank & Trust Co. Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Central Bank & Trust Co. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.2% during the fourth quarter, Holdings Channel reports. The fund owned 17,140 shares of the medical equipment provider’s stock after selling 3,062 shares during the period. Intuitive Surgical makes up approximately 1.4% of Central Bank & Trust Co.’s portfolio, making the stock its 22nd largest position. Central Bank & Trust Co.’s holdings in Intuitive Surgical were worth $8,946,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp lifted its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC lifted its position in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the period. Fisher Asset Management LLC increased its holdings in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. raised its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,509 shares of company stock valued at $22,602,212. Company insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Robert W. Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Up 1.5 %

Shares of ISRG stock opened at $592.64 on Tuesday. The firm has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The stock has a fifty day moving average of $540.66 and a 200 day moving average of $499.64. Intuitive Surgical, Inc. has a 52 week low of $362.14 and a 52 week high of $597.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.